1. Home
  2. EXEL vs FN Comparison

EXEL vs FN Comparison

Compare EXEL & FN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXEL
  • FN
  • Stock Information
  • Founded
  • EXEL 1994
  • FN 1999
  • Country
  • EXEL United States
  • FN Cayman Islands
  • Employees
  • EXEL N/A
  • FN N/A
  • Industry
  • EXEL Biotechnology: Biological Products (No Diagnostic Substances)
  • FN Telecommunications Equipment
  • Sector
  • EXEL Health Care
  • FN Utilities
  • Exchange
  • EXEL Nasdaq
  • FN Nasdaq
  • Market Cap
  • EXEL 10.0B
  • FN 8.8B
  • IPO Year
  • EXEL 2000
  • FN 2010
  • Fundamental
  • Price
  • EXEL $34.59
  • FN $235.98
  • Analyst Decision
  • EXEL Buy
  • FN Buy
  • Analyst Count
  • EXEL 17
  • FN 7
  • Target Price
  • EXEL $32.18
  • FN $252.14
  • AVG Volume (30 Days)
  • EXEL 1.7M
  • FN 531.0K
  • Earning Date
  • EXEL 02-04-2025
  • FN 02-03-2025
  • Dividend Yield
  • EXEL N/A
  • FN N/A
  • EPS Growth
  • EXEL 441.02
  • FN 25.19
  • EPS
  • EXEL 1.55
  • FN 8.45
  • Revenue
  • EXEL $2,081,598,000.00
  • FN $3,001,718,000.00
  • Revenue This Year
  • EXEL $20.59
  • FN $18.52
  • Revenue Next Year
  • EXEL $1.50
  • FN $14.02
  • P/E Ratio
  • EXEL $22.41
  • FN $27.39
  • Revenue Growth
  • EXEL 17.31
  • FN 12.20
  • 52 Week Low
  • EXEL $19.20
  • FN $159.69
  • 52 Week High
  • EXEL $36.97
  • FN $278.38
  • Technical
  • Relative Strength Index (RSI)
  • EXEL 51.61
  • FN 47.25
  • Support Level
  • EXEL $34.30
  • FN $229.48
  • Resistance Level
  • EXEL $36.22
  • FN $256.24
  • Average True Range (ATR)
  • EXEL 0.75
  • FN 8.95
  • MACD
  • EXEL -0.29
  • FN 0.19
  • Stochastic Oscillator
  • EXEL 25.09
  • FN 26.13

About EXEL Exelixis Inc.

Exelixis is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its lead molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.

About FN Fabrinet

Fabrinet provides advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and sub-systems, industrial lasers, automotive components, medical devices, and sensors. The company offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, complex printed circuit board assembly, advanced packaging, integration, final assembly, and testing. The company generates the majority of its revenue from North America and Asia-Pacific, with the rest from Europe.

Share on Social Networks: